LeMaitre Vascular, Inc. (LMAT) SEC Filings & Earnings Calls

Leadership transition risk, but mitigated by continued board service.

“President retiring; no successor named yet.”

Product recall impact

“Catheter sales decreased $0.9 million due to the increased sales volumes related to the April 2025 recall of our TufTex Over-the-Wire, Pruitt Occlusion, and Pruitt Irrigation catheters.” · word for word

Manufacturing transition costs

“R&D expenses increased 37% in Q2 2026 driven by higher third-party service fees and general supplies associated with the current transfer of our allograft tissue processing from our Fox River Grove facility to Burlington.”

Catheter sales down 11% due to recall-driven overstocking in prior year; organic growth ex-catheters was 12%.

“Catheters were down 11% in the quarter due to recall-driven overstocking in Q2 2025. Q2 organic growth was 12% excluding catheters.” · word for word

Foreign exchange exposure

“approximately 44% of our sales took place outside of the United States, largely in currencies other than the U.S. dollar.” · word for word

Product discontinuation impact

“During 2025, we made the decision to terminate our cardiovascular porcine patch distribution agreement with Elutia. This product totaled approximately $1.8 million in 2025 revenues.” · word for word

ERP implementation risk

“As of March 31, 2026, we have net capitalized costs on our balance sheet of $4.6 million associated with this ERP system.” · word for word

No specific risk factors highlighted beyond standard boilerplate; strong performance mitigates near-term risks.

“Standard forward-looking statement disclaimer; no adverse trends noted.”

Sterilization facility disruption

“Any permanent or temporary closures or disruption to the operations of these facilities could impair our ability to sterilize certain of our products, which could negatively affect our sales.” · word for word

Debt service on convertible notes

“Servicing our 2.50% convertible senior notes requires a significant amount of cash, and we may not have sufficient cash flow to pay our debt.” · word for word

No material risks identified; strong financial position with $359M cash and no debt.

Convertible note dilution risk

“The initial conversion rate is 8.3521 shares of common stock per $1,000 principal amount of the Convertible Notes, which represents an initial conversion price of approximately $119.73 per share of common stock” · word for word

Foreign exchange exposure

“approximately 43% of our sales took place outside of the United States, largely in currencies other than the U.S. dollar.” · word for word

Non-recurring ERTC benefit inflates GAAP results; adjusted metrics provide cleaner view.

“Q3 2025 results include a non-recurring benefit from the Employee Retention Tax Credit.” · word for word

No material risks disclosed beyond standard forward-looking statements.

“Forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995.” · word for word